Abstract
Crohn’s disease in children is a chronic inflammatory disorder of the gastrointestinal tract, characterized by progressive course, variable clinical manifestations, and a high risk of both systemic and local complications. In pediatric practice, the diagnosis and management of Crohn’s disease remain challenging due to the lack of specific biomarkers, the diversity of clinical presentations, and age-related characteristics of patients. The aim of this study was to analyze the clinical features, laboratory findings, disease course, and therapeutic strategies in children with Crohn’s disease based on data from a pediatric gastroenterology department registry. The study included data from 29 children with a verified diagnosis of Crohn’s disease for the period from 2009 to March 2025. A retrospective descriptive analysis of medical records was performed. Parameters assessed included age at disease onset, sex, symptom frequency, disease activity index (PCDAI), laboratory values, presence of complications, and treatment strategies, including biologic therapy. The most frequent initial symptoms were abdominal pain (100 %), weight loss (63 %), asthenic syndrome (55 %), and diarrhea (42 %). Children under 10 years of age more commonly presented with signs of pronounced inflammation, such as anemia, elevated erythrocyte sedimentation rate, C-reactive protein, and thrombocytosis. Complicated disease course was identified in 41 % of cases. The average diagnostic delay was 6.5 months. Biologic therapy was initiated in 6 patients based on strict indications. These findings highlight the importance of early diagnosis, the use of phenotypic classifications, and a multidisciplinary approach. The results may contribute to the development of clinical pathways and standards of care for pediatric Crohn’s disease.
Acknowledgments
The authors would like to express their gratitude to Children’s City Clinical Hospital No. 9 (Ekaterinburg), represented by Chief Physician I. P. Ogarkov, for providing opportunities for diagnosis, treatment, and observation of the patient. They also wish to thank the staff of the gastroenterology department for their skilled assistance in collecting and analyzing clinical data.
For citation
Sharuda EV, Sheina OP, Ilyinskaya OE, Estebesova YuR. Experience in managing children with Crohn’s disease in a gastroenterology department. USMU Medical Bulletin. 2025;10(3):e00173. DOI: https://doi.org/10.52420/usmumb.10.3.e00173. EDN: https://elibrary.ru/GCEOJV.
References
Ruemmele FM, Veres G, Kolho KL, Griffiths A, Levine A, Escher JC, et al. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn’s disease. Journal of Crohn’s and Colitis. 2014;8(10):1179–1207. DOI: https://doi.org/10.1016/j.crohns.2014.04.005.
Benchimol EI, Fortinsky KJ, Gozdyra P, Van den Heuvel M, Van Limbergen J, Griffiths AM. Epidemiology of pediatric inflammatory bowel disease: A systematic review of international trends. Inflammatory Bowel Diseases. 2011;17(1):423–439. DOI: https://doi.org/10.1002/ibd.21349.
Van Limbergen J, Russell RK, Drummond HE, Aldhous MC, Round NK, Nimmo ER, et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology. 2008;135(4):1114–1122. DOI: https://doi.org/10.1053/j.gastro.2008.06.081.
Levine A, Griffiths A, Markowitz J, Wilson DC, Turner D, Russell RK, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: The Paris classification. Inflammatory Bowel Diseases. 2011;17(6):1314–1321. DOI: https://doi.org/10.1002/ibd.21493.
Eidelwein AP, Cuffari C, Abadom V, Oliva-Hemker M. Infliximab efficacy in pediatric ulcerative colitis. Inflammatory Bowel Diseases. 2005;11(3):213–218. DOI: https://doi.org/10.1097/01.mib.0000160803.44449.a5.
Uhlig HH, Schwerd T, Koletzko S, Shah N, Kammermeier J, Elkadri A, et al. The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology. 2014;147(5):990–1007. DOI: https://doi.org/10.1053/j.gastro.2014.07.023.
Sýkora J, Pomahačová R, Kreslová M, Cvalínová D, Štych P, Schwarz J. Current global trends in the incidence of pediatric-onset inflammatory bowel disease. World Journal of Gastroenterology. 2018;24(25):2741–2763. DOI: https://doi.org/10.3748/wjg.v24.i25.2741.
Uhlig HH. Monogenic diseases associated with intestinal inflammation: Implications for the understanding of inflammatory bowel disease. Gut. 2013;62(12):1795–1805. DOI: https://doi.org/10.1136/gutjnl-2012-303956.
Hyams JS, Ferry GD, Mandel FS, Gryboski JD, Kibort PM, Kirschner BS, et al. Development and validation of a pediatric Crohn’s disease activity index. Journal of Pediatric Gastroenterology and Nutrition. 1991;12(4):439–447. PMID: https://pubmed.gov/1678008.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
Copyright © 2025 Sharuda E. V., Sheina O. P., Ilyinskaya O. E., Estebesova Yu. R.